GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells
Open Access
- 14 October 2021
- journal article
- research article
- Published by Springer Nature in Oncogenesis
- Vol. 10 (10) , 1-12
Abstract
Golgi protein 73 (GP73) and alpha fetoprotein (AFP) serve as biomarkers for the diagnosis of hepatocellular carcinoma (HCC), and their serum levels correlate with patients’ outcomes. However, the mechanisms underlying these correlations are unknown. Here we show that GP73 increased the secretion of AFP through direct binding to AFP, thereby promoting the proliferation and metastasis of HCC cells that expressed AFP and its receptor (AFPR). Extracellular GP73 contributed to the proliferation and metastasis of HCC cells independent of AFP and AFPR. Moreover, extracellular AFP and GP73 synergized to enhance the malignant phenotype of HCC cells. Furthermore, extracellular GP73 and AFP inhibited the antitumor effects of sorafenib and synergistically increased the drug resistance of HCC cells. These findings, which reveal the mechanism of GP73-mediated secretion of AFP and its effects on the malignant phenotype of HCC cells, provide a comprehensive theoretical basis for the diagnosis and treatment of HCC and identify potential drug targets.Keywords
This publication has 42 references indexed in Scilit:
- Hepatitis B virus-induced hepatocellular carcinomaCancer Letters, 2014
- Golgi phosphoprotein 2 in physiology and in diseasesCell & Bioscience, 2012
- The Golgi Localization of GOLPH2 (GP73/GOLM1) Is Determined by the Transmembrane and Cytoplamic SequencesPLOS ONE, 2011
- Alpha‐fetoprotein: A new member of intracellular signal molecules in regulation of the PI3K/AKT signaling in human hepatoma cell linesInternational Journal of Cancer, 2010
- AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCCJournal of Gastroenterology, 2010
- Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?Clinical Cancer Research, 2010
- Alpha fetoprotein is a novel protein‐binding partner for caspase‐3 and blocks the apoptotic signaling pathway in human hepatoma cellsInternational Journal of Cancer, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinomaJournal of Hepatology, 2005
- Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinomaJournal of Hepatology, 2004